SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-092800
Filing Date
2016-04-05
Accepted
2016-04-05 16:15:22
Documents
1
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v436227_3.html 3  
1 OWNERSHIP DOCUMENT v436227_3.xml 3 3122
  Complete submission text file 0001144204-16-092800.txt   4890
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
Rackear Andrew D. (Reporting) CIK: 0001408617 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 161554670